Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 2
1981 4
1982 4
1983 2
1984 2
1985 3
1986 3
1987 10
1988 5
1989 12
1990 31
1991 26
1992 25
1993 35
1994 37
1995 41
1996 37
1997 58
1998 82
1999 78
2000 105
2001 112
2002 142
2003 195
2004 272
2005 327
2006 357
2007 431
2008 559
2009 614
2010 759
2011 899
2012 1058
2013 1134
2014 1409
2015 1515
2016 1522
2017 1643
2018 1871
2019 2083
2020 2536
2021 2890
2022 2482
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

22,818 results
Results by year
Filters applied: . Clear all
Page 1
Biomarkers in oral immunotherapy.
Zhu H, Tang K, Chen G, Liu Z. Zhu H, et al. J Zhejiang Univ Sci B. 2022 Sept 15;23(9):705-731. doi: 10.1631/jzus.B2200047. J Zhejiang Univ Sci B. 2022. PMID: 36111569 Free PMC article. Review.
Neuroimaging Assessment of Pain.
Luo J, Zhu HQ, Gou B, Wang XQ. Luo J, et al. Among authors: zhu hq. Neurotherapeutics. 2022 Jul 28. doi: 10.1007/s13311-022-01274-z. Online ahead of print. Neurotherapeutics. 2022. PMID: 35902535
Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS.
Miller TM, Cudkowicz ME, Genge A, Shaw PJ, Sobue G, Bucelli RC, Chiò A, Van Damme P, Ludolph AC, Glass JD, Andrews JA, Babu S, Benatar M, McDermott CJ, Cochrane T, Chary S, Chew S, Zhu H, Wu F, Nestorov I, Graham D, Sun P, McNeill M, Fanning L, Ferguson TA, Fradette S; VALOR and OLE Working Group. Miller TM, et al. Among authors: zhu h. N Engl J Med. 2022 Sep 22;387(12):1099-1110. doi: 10.1056/NEJMoa2204705. N Engl J Med. 2022. PMID: 36129998 Clinical Trial.
Prostate cancer treatment - China's perspective.
Liu J, Dong L, Zhu Y, Dong B, Sha J, Zhu HH, Pan J, Xue W. Liu J, et al. Among authors: zhu hh. Cancer Lett. 2022 Sep 24;550:215927. doi: 10.1016/j.canlet.2022.215927. Online ahead of print. Cancer Lett. 2022. PMID: 36162714
Recent advances of eosinophils and its correlated diseases.
Tao Z, Zhu H, Zhang J, Huang Z, Xiang Z, Hong T. Tao Z, et al. Among authors: zhu h. Front Public Health. 2022 Jul 25;10:954721. doi: 10.3389/fpubh.2022.954721. eCollection 2022. Front Public Health. 2022. PMID: 35958837 Free PMC article. Review.
lncRNA-GM targets Foxo1 to promote T cell-mediated autoimmunity.
Chen Y, Liu J, Zhang X, Zhu H, Wang Y, Li Z, Liu Y, Liu S, Liu S, Li N, Chen K, Cao X. Chen Y, et al. Among authors: zhu h. Sci Adv. 2022 Aug 5;8(31):eabn9181. doi: 10.1126/sciadv.abn9181. Epub 2022 Aug 5. Sci Adv. 2022. PMID: 35930633 Free PMC article.
Spatially restricted drivers and transitional cell populations cooperate with the microenvironment in untreated and chemo-resistant pancreatic cancer.
Cui Zhou D, Jayasinghe RG, Chen S, Herndon JM, Iglesia MD, Navale P, Wendl MC, Caravan W, Sato K, Storrs E, Mo CK, Liu J, Southard-Smith AN, Wu Y, Naser Al Deen N, Baer JM, Fulton RS, Wyczalkowski MA, Liu R, Fronick CC, Fulton LA, Shinkle A, Thammavong L, Zhu H, Sun H, Wang LB, Li Y, Zuo C, McMichael JF, Davies SR, Appelbaum EL, Robbins KJ, Chasnoff SE, Yang X, Reeb AN, Oh C, Serasanambati M, Lal P, Varghese R, Mashl JR, Ponce J, Terekhanova NV, Yao L, Wang F, Chen L, Schnaubelt M, Lu RJ, Schwarz JK, Puram SV, Kim AH, Song SK, Shoghi KI, Lau KS, Ju T, Chen K, Chatterjee D, Hawkins WG, Zhang H, Achilefu S, Chheda MG, Oh ST, Gillanders WE, Chen F, DeNardo DG, Fields RC, Ding L. Cui Zhou D, et al. Among authors: zhu h. Nat Genet. 2022 Sep;54(9):1390-1405. doi: 10.1038/s41588-022-01157-1. Epub 2022 Aug 22. Nat Genet. 2022. PMID: 35995947 Free PMC article.
22,818 results
You have reached the last available page of results. Please see the User Guide for more information.